Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF00717743.pdf
Reference51 articles.
1. Absolom DR (1986) Basic methods for the study of phagocytosis. Methods Enzymol 132:95?180
2. Arrang J-M, Garbarg M, Schwartz J-C (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832?837
3. Arrang J-M, Garbarg M, Quach TT, Tuong MDT, Yerimian E, Schwartz J-C (1985) Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 111:73?84
4. Arrang J-M, Garbarg M, Lancelot J-C, Lecomte J-M, Pollard H, Robba M, Schunack W, Schwartz J-C (1987) Highly potent and selective ligands for histamine H3-receptors. Nature 327:117?123
5. Ash ASF, Schild HO (1966) Receptors mediating some actions of histamine. Br J Pharmacol Chemother 27:427?439
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1);Journal of Evolutionary Biochemistry and Physiology;2022-01
2. Histamine in cancer immunology and immunotherapy. Current status and new perspectives;Pharmacology Research & Perspectives;2021-10
3. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms;Frontiers in Pharmacology;2021-03-23
4. Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis;Digestive Diseases and Sciences;2021-02-24
5. Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19;American Journal of Gastroenterology;2020-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3